fda schizophrenia news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

USA TODAY on MSN · 18h

This FDA-approved drug promises a new way to treat schizophrenia

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments

Time on MSN · 2d

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.

Pharmaceutical Technology1h

FDA approves PureTech’s KarXT to treat schizophrenia in adults

PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

FDA approves first new medication to treat schizophrenia in more than 30 years

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

FDA approves first new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results